dc.creatorMunante-Cardenas, JL
dc.creatorde Assis, AF
dc.creatorOlate, S
dc.creatorLyrio, MCN
dc.creatorde Moraes, M
dc.date2009
dc.dateNOV
dc.date2014-11-13T19:48:45Z
dc.date2015-11-26T16:02:21Z
dc.date2014-11-13T19:48:45Z
dc.date2015-11-26T16:02:21Z
dc.date.accessioned2018-03-28T22:51:47Z
dc.date.available2018-03-28T22:51:47Z
dc.identifierJournal Of The American Dental Association. Amer Dental Assoc, v. 140, n. 11, n. 1373, n. 1376, 2009.
dc.identifier0002-8177
dc.identifierWOS:000271724800012
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/77320
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/77320
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/77320
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1265046
dc.descriptionBackground. Histoplasmosis is a deep fungus infection that occurs worldwide and is caused Histoplasma capsulatum. Oral histoplasmosis has been of considerable importance in recent years because it occurs frequently in immunosuppressed patients, more often in those who test positive for the human immunodeficiency virus (HIV). However the literature contains reports of histoplasmosis in immunocompetent patients, especially in endemic areas. Case Description. The authors describe a case of an HIV-negative, immunocompetent 60-year-old man with ulcerative and painful oral lesions. The clinician included squamous cell carcinoma and systemic mycosis in the differential diagnosis. After the patient underwent a biopsy and a definitive diagnosis was reached, this initial treatment regimen included itraconazole (200 milligrams per day for one month), nystatin and chlorhexidine mouthrinse (0.12 percent, 10 milliliters, two times a day). The itraconazole treatment was continued for three more months (100 mg daily) until the lesions had resolved completely. Clinical Implications. Clinicians need to conduct a careful clinical evaluation and make an accurate diagnosis of ulcerated oral lesions. Knowledge of the oral manifestations of histoplasmosis may enable clinicians to reach a diagnosis earlier and initiate therapy more quickly.
dc.description140
dc.description11
dc.description1373
dc.description1376
dc.languageen
dc.publisherAmer Dental Assoc
dc.publisherChicago
dc.publisherEUA
dc.relationJournal Of The American Dental Association
dc.relationJ. Am. Dent. Assoc.
dc.rightsfechado
dc.sourceWeb of Science
dc.subjectOral pathology
dc.subjectfungal infections
dc.subjectoral ulcers
dc.subjectantifungal agents
dc.subjectProgressive Disseminated Histoplasmosis
dc.subjectInfection
dc.subjectAids
dc.titleTreating oral histoplasmosis in an immunocompetent patient
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución